Epsilon M&A Deal Report - ESE (QIAGEN Lake Constance GmbH)
Transaction Multiples for the Valuation of Private Companies
Qiagen / ESE (QIAGEN Lake Constance GmbH)
No EMAT :
21075
Announced Date :
12/01/2010
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Qiagen
Target :
ESE (QIAGEN Lake Constance GmbH)
Country :
Germany
Sector of activity :
- Medical Equipment > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Diagnostic Medical Equipment
Business Description :
Founded in 1997, ESE GmbH develops and manufactures UV and fluorescence optical measurement devices . > Its products include lateral flow immunoassay readers used in applications, such as aflatoxin...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | ||||||||
| Current | 
|
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Diagnostic Medical Equipment » = 37
| Date | Acquirer | Target | Country | Multiples | See details |
| 15/11/2005 | Allergan | Inamed | United States | * | 21070 |
| 18/05/2005 | L'Oreal | SkinCeuticals | United States | * | 21060 |
Source: Epsilon Research / EMAT
